Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery

Aakriti G. Shukla, Pradeep Y. Ramulu

Research output: Contribution to journalArticlepeer-review


The use of antithrombotic therapy is rising as the population of older adults grows and novel agents with wider indications emerge. Likewise, surgical treatment of glaucoma may become increasingly common as the prevalence of glaucoma increases and innovative treatment options are developed. These trends highlight the need to understand how best to manage antithrombotic therapy in the context of glaucoma surgery. This review article describes current literature on antithrombotic therapy and perioperative thromboembolic risk evaluation based on individual factors. In addition, guidance is offered on the management of antithrombotic therapy in the setting of each type of glaucoma surgery, with an emphasis on a multidisciplinary approach involving the patients' treating physicians.

Original languageEnglish (US)
Pages (from-to)732-741
Number of pages10
JournalJournal of glaucoma
Issue number9
StatePublished - Sep 1 2020


  • anticoagulant
  • antiplatelet
  • antithrombotic
  • blood thinners
  • glaucoma surgery
  • hyphema
  • minimally invasive glaucoma surgery
  • suprachoroidal hemorrhage
  • vitreous hemorrhage

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery'. Together they form a unique fingerprint.

Cite this